U.S. Markets closed

Rejuvel Bio-Sciences, Inc. (NUUU)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0001-0.0001 (-50.00%)
At close: 3:29PM EDT

Rejuvel Bio-Sciences, Inc.

Chase Bank Building
150 SE 2nd Avenue Suite 403
Miami, FL 33131
United States
800-670-0448
http://www.rejuvel.com

Sector(s)Consumer Defensive
IndustryHousehold & Personal Products
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Charles J. ScimecaCEO & DirectorN/AN/A1945
Mr. Matthew J. CohenCFO & DirectorN/AN/A1958
Mr. David PollockPres of Zero Gravity Sciences, IncN/AN/A1965
Amounts are as of December 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.

Corporate Governance

Rejuvel Bio-Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.